With most publicly traded medical device companies having released their sales and earnings figures for the first quarter of 2017, Medtech Insight picks out the winners that reported good news, those that are facing particular challenges, and a few worth paying especially close attention to in the coming months.
Johnson & Johnson (JNJ) landed in the losers category three months ago, but can count themselves as winners this quarter because of the progress they've made in the ongoing restructuring of their medical device businesses, selling off lower growth units while investing in higher growth franchises
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?